Breast Carcinoma
📧 Sign up to get email alerts when something new happens for Breast Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating pembrolizumab (MK-3475) as adjuvant therapy for triple-negative breast cancer; status ACTIVE_NOT_RECRUITIN…
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 trial updating pembrolizumab (MK-3475) as adjuvant therapy for triple-negative breast cancer; study status ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer [Phase 2]
A Phase 2 trial of metformin hydrochloride and doxycycline in localized breast or uterine cancers was terminated, with results posted.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer [Phase 2]
A Phase 2 trial sponsored by Mayo Clinic compares at-home cancer-directed therapy to in-clinic treatment for patients with various advanced …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial [Phase 1]
This is an early-stage (Phase 1) clinical trial evaluating the combination of DS-8201a (trastuzumab deruxtecan) and AZD6738 (camonsertib) fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating circulating tumor DNA to guide changes in standard chemotherapy for metastatic HER2-negative breast cancer…
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
A completed clinical trial update examining factors influencing cascade genetic testing among women with hereditary gynecologic cancers and …
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: 64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy [EARLY_Phase 1]
This early Phase 1 trial evaluated the use of copper-64 labeled DOTA-alendronate PET imaging to locate and characterize breast calcification…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating patient-derived organoid-guided personalized treatment versus physician's choice in breast cancer is curre…
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: The p53 Breast Cancer Trial [Phase 2]
Phase 2 clinical trial update for a p53-targeted breast cancer study, currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults [Phase 4]
Phase 4 clinical trial update assessing optimal dosing of oral anticancer drugs in older adults, with multiple cancer indications listed.
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial assessing ruxolitinib in combination with trastuzumab for metastatic HER2-positive breast cancer has completed with posted r…
-
CLINICAL_TRIALS trial_result · 2023-01-09Clinical Trial Update: Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery [Phase 3]
Phase 3 trial update on using fluorescence for sentinel lymph node identification in cancer surgery; completed study.
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating eribulin mesylate in patients with previously treated metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer [Phase 2]
Phase 2 trial updates trametinib combined with an AKT inhibitor (GSK2141795) in metastatic triple-negative breast cancer; study completed wi…
-
CLINICAL_TRIALS research · 2019-01-03Clinical Trial Update: Circadian Thermal Sensing to Detect Breast Disease [Phase 1, Phase 2]
Clinical trial update on circadian thermal sensing for detecting breast disease, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2018-10-05Clinical Trial Update: Topical Cryotherapy in Reducing Pain in Patients With Chemotherapy Induced Peripheral Neuropathy or Paclitaxel Induced Acute Pain Syndrome [NA]
Clinical trial update on topical cryotherapy aiming to reduce pain in patients experiencing chemotherapy-induced peripheral neuropathy or pa…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating Akt inhibitor MK2206 in advanced breast cancer has completed; results posted in 2016.